Exforge HCT FDA Approval History
FDA Approved: Yes (First approved April 30, 2009)
Brand name: Exforge HCT
Generic name: amlodipine, valsartan and hydrochlorothiazide
Dosage form: Tablets
Company: Novartis Pharmaceuticals Corporation
Treatment for: High Blood Pressure
Exforge HCT is a combination of the calcium channel blocker amlodipine, the angiotensin receptor blocker valsartan, and the diuretic hydrochlorothiazide indicated for the once-daily combination treatment of hypertension.
Development timeline for Exforge HCT
| Date | Article |
|---|---|
| Apr 30, 2009 | Approval FDA approves Exforge HCT - the only high blood pressure treatment to combine three medications in a single pill |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
